AntlerA Therapeutics
AntlerA Therapies is a regenerative medicine startup that is working on protein therapeutics that modulate developmental signaling pathways while also mobilizing tissue stem cell activity to enable endogenous tissue repair. They generated powerful antibody-like molecules (ANTs) that activate certain Frizzed receptor complexes using their unique protein engineering platform.
Industries
biotechnology
medical
therapeutics
Nr. of Employees
small (1-50)
AntlerA Therapeutics
Patents
Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene
US-12600785-B2
View Details
Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene
US-12600785-B2
View Details